Immunosuppressive effects of silicon phthalocyanine photodynamic therapy

Photochemistry and Photobiology

Volumn 70, Issue 1, 1999, Pages 72-77

  Reddan, Julie C ^a   Anderson, Cathy Young ^a   Xu, Hui ^b   Hrabovsky, Sharon ^a   Freye, Kristin ^a   Fairchild, Roberta ^a   Tubesing, Karen A ^a   Elmets, Craig A ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(TRI N HEXYLSILOXY)(2,3 NAPHTHALOCYANINATO)SILICON; BIS(TRI-N-HEXYLSILOXY)(2,3-NAPHTHALOCYANINATO)SILICON; INDOLE DERIVATIVE; ORGANOSILICON DERIVATIVE; PHOTOSENSITIZING AGENT; SILANE DERIVATIVE; SILICON PHTHALOCYANINE;

ANIMAL; ARTICLE; C3H MOUSE; DRUG EFFECT; FEMALE; IMMUNOLOGICAL TOLERANCE; MOUSE; PHOTOCHEMOTHERAPY;

ANIMALS; FEMALE; IMMUNE TOLERANCE; INDOLES; MICE; MICE, INBRED C3H; ORGANOSILICON COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SILANES;

EID: 0033163325     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1999.tb01951.x     Document Type: Article

References (50)

1. Dougherty, T. (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
2. Dougherty, T. J. and S. L. Marcus (1992) Photodynamic therapy. Eur. J. Cancer 28A, 1734-1742.
3. Gomer, C. J. (1991) Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem. Photobiol. 54, 1093-1107.
4. Henderson, B. and T. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-157.
5. McCaughan, Jr., J. S. (1987) Overview of experience with photodynamic therapy for malignancy in 192 patients. Photochem. Photobiol. 46, 903-909.
6. Pass, H. I. (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85, 443-456.
7. Manyak, M., A. Russo, P. Smith and E. Glatstein (1988) Photodynamic therapy. J. Clin. Oncol. 6, 380-391.
8. Lightdale, C. J., S. K. Heier, N. E. Marcon, J. S. McCaughan, Jr., H. Gerdes, B. F. Overholt, M. V. Sivak, Jr., G. V. Stiegmann and H. R. Nava (1995) Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest. Endosc. 42, 507-512.
9. Heier, S., K. Rothman, I. Heier and W. Rosenthal (1995) Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 109, 63-67.
10. Overholt, B. F. and M. Panjehpour (1997) Photodynamic therapy for Barrett's esophagus. Gastrointest. Endosc. Clin. North Am. 7, 207-220.
11. Schweitzer, V., S. Bologna and S. Batra (1993) Photodynamic therapy for treatment of esophageal cancer: a preliminary report. Laryngoscope 103, 699-703.
12. Kato, H., T. Okunaka and H. Shimatani (1996) Photodynamic therapy for early stage bronchogenic carcinoma. J. Clin. Laser Med. Surg. 14, 235-238.
13. Nseyo, U. O., J. DeHaven, T. J. Dougherty, W. R. Potter, D. L. Merrill, S. L. Lundahl and D. L. Lamm (1998) Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. J. Clin. Laser Med. Surg. 16, 61-68.
14. Abramson, A., M. Shikowitz, V. Mullooly, B. Steinberg, C. Amella and H. Rothstein (1992) Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 118, 25-29.
15. Biel, M. (1994) Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope 104, 399-403.
16. Biel, M. (1996) Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. Arch. Otolaryngol. Head Neck Surg. 122, 1261-1265.
17. Dilkes, M., M. DeJode, Q. Gardiner, G. Kenyon and P. McKelvie (1995) Treatment of head and neck cancer with photodynamic therapy: results after one year. J. Laryngol. Otol. 109, 1072-1076.
18. Lofgren, L., S. Hallgren, E. Nilsson, A. Westerborn, C. Nilsson and J. Reizenstein (1995) Photodynamic therapy for recurrent nasopharyngeal cancer. Arch. Otolaryngol. Head Neck Surg. 121, 997-1002.
19. Allison, R. R., T. S. Mang and B. D. Wilson (1998) Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin. Cutan. Med. Surg. 17, 153-163.
20. Wilson, B. D., T. S. Mang, H. Stoll, C. Jones, M. Cooper and T. J. Dougherty (1992) Photodynamic therapy for the treatment of basal cell carcinoma. Arch. Dermatol. 128, 1597-1601.
21. Hebeda, K. M., M. T. Huizing, P. A. Brouwer, F. W. van der Meulen, H. J. Hulsebosch, P. Reiss, J. Oosting, C. H. Veenhof and P. J. Bakker (1995) Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10, 61-70.
22. Taber, S. W., V. H. Fingar and T. J. Wieman (1998) Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J. Surg. Oncol. 68, 209-214.
23. Muller, P. J. and B. C. Wilson (1995) Photodynamic therapy for recurrent supratentorial gliomas. Semin. Surg. Oncol. 11, 346-354.
24. Zaidi, S., R. Agarwal, G. Eichler, B. Rihter, M. Kenney and H. Mukhtar (1993) Photodynamic effects of new silicon phthalocyanines: in vitro studies utilizing rat hepatic microsomes and human erythrocyte ghosts as model membrane sources. Photochem. Photobiol. 58, 204-210.
25. Zaidi, S. I., N. L. Oleinick, M. T. Zaim and H. Mukhtar (1993) Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem. Photobiol. 58, 771-776.
26. Ratkay, L. G., R. K. Chowdhary, A. Iamaroon, A. M. Richter, H. C. Neyndorff, E. C. Keystone, J. D. Waterfield and J. G. Levy (1998) Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis Rheum. 41, 525-534.
27. Elmets, C. A. and K. D. Bowen (1986) Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res. 46, 1608-1611.
28. Krutmann, J. and C. Elmets (1995) Photoimmunology. Blackwell Scientific, Oxford.
29. Lynch, D. H., S. Haddad, V. J. King, M. J. Ott, R. C. Straight and C. J. Jolles (1989) Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem. Photobiol. 49, 453-458.
30. Anderson, C. Y., K. Freye, K. A. Tubesing, Y. S. Li, M. E. Kenney, H. Mukhtar and C. A. Elmets (1998) A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Photochem. Photobiol. 67, 332-336.
31. He, J., H. E. Larkin, Y. S. Li, D. Rihter, S. I. Zaidi, M. A. Rodgers, H. Mukhtar, M. E. Kenney and N. L. Oleinick (1997) The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem. Photobiol. 65, 581-586,
32. Oleinick, N., A. Antunez, M. Clay, B. Rihter and M. Kenney (1993) New phthalocyanine photosensitizers for photodynamic therapy. Photochem. Photobiol. 57, 242-247.
33. Anderson, C., S. Hrabovsky, Y. McKinley, K. Tubesing, H. P. Tang, R. Dunbar, H. Mukhtar and C. A. Elmets (1997) Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem. Photobiol. 65, 895-901.
34. Henderson, B. W., S. M. Waldrow, T. S. Mang, W. R. Potter, P. B. Malone and T. J. Dougherty (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 52, 4914-4921.
35. Elmets, C., P. Bergstresser, R. Tigelaar, P. Wood and 3. Streilein (1983) Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J. Exp. Med. 158, 781-794.
36. Ullrich, S. (1995) The role of epidermal cytokines in the generation of cutaneous immune reactions and ultraviolet radiation induced immune suppression. Photochem. Photobiol. 62, 389-401.
37. Rivas, J. M. and S. E. Ullrich (1992) Systemic suppression of DTH by supernatants from UV irradiated keratinocytes: an essential role for IL-10. J. Immunol. 149, 3865-3871.
38. Toews, G. B., P. R. Bergstresser and J. W. Streilein (1980) Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124, 445-453.
39. Leong, S., A. H. Chan, J. G. Levy and D. W. Hunt (1996) Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochem. Photobiol. 64, 751-757.
40. Obochi, M. O., L. G. Ratkay and J. G. Levy (1997) Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. Transplantation 63, 810-817.
41. Tarpley, J., C. Potvin and P. Chretien (1975) Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy. Cancer 35, 638-644.
42. Eilber, F. and D. Morton (1970) Impaired immunologic reactivity and recurrence following cancer surgery. Cancer 25, 362-367.
43. Miyauchi, H. and T. Horio (1995) Ultraviolet B-induced local immunosuppression of contact hypersensitivity is modulated by ultraviolet irradiation and hapten application. J. Invest. Dermatol. 104, 364-369.
44. Yoshikawa, T., V. Rae, W. Bruins-Slot, J. W. Van den Berg, J. R. Taylor and J. W. Streilein (1990) Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol. 95, 530-536.
45. Cooper, K. D., L. Oberhelman, T. A. Hamilton, O. Baadsgaard, M. Terhune, G. LeVee, T. Anderson and H. Koren (1992) UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR' epidermal macrophage induction and Langerhans cell depletion. Proc. Natl. Acad. Sci. USA 89, 8497-8501.
46. Korbelik, M., G. Krosl, J. Krosl and G. J. Dougherty (1996) The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 56, 5647-5652.
47. Korbelik, M., V. Naraparaju and N. Yamamoto (1997) Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br. J. Cancer 75, 202-207.
48. Krosl, G., M. Korbelik, J. Krosl and G. J. Dougherty (1996) Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res. 56, 3281-3286.
49. Vink, A. A., D. B. Yarosh and M. L. Kripke (1996) Chromophore for UV-induced immunosuppression: DNA. Photochem. Photobiol. 63, 383-386.
50. Lynch, D. H., S. Haddad, V. J. King, M. J. Ott, R. C. Straight and C. J. Jolles (1989) Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem. Photobiol. 49, 453-458.